表紙
市場調査レポート

世界のニードルフリー(無針)ドラッグデリバリー市場の展望

Needle-Free Delivery Technology Market Forecast 2015-2025: Opportunities for Leading Companies

発行 Visiongain Ltd 商品コード 233147
出版日 ページ情報 英文 208 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=134.80円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
世界のニードルフリー(無針)ドラッグデリバリー市場の展望 Needle-Free Delivery Technology Market Forecast 2015-2025: Opportunities for Leading Companies
出版日: 2015年05月18日 ページ情報: 英文 208 Pages
概要

当レポートでは、針を使用しないニードルフリードラッグデリバリーの市場について調査分析し、無針ドラッグデリバリー技術の必要性、メリット・デメリット、有益となる臨床現場、現在利用可能なジェットインジェクターおよび競合技術/製品の概要、現在開発中のジェットインジェクターおよび競合技術/製品の概要、ジェットインジェクターおよび競合製品の売上予測、市場影響因子の分析、専門家の見解などをまとめてお届けいたします。

第1章 レポート概要

第2章 イントロダクション:薬剤/ワクチンのニードルフリー(無針)技術

  • ニードルフリー(無針)技術とは
    • 針刺し損傷
  • 無針デリバリー技術市場
  • ジェット式注射器
    • 多用途ノズルジェット注射器 (MUNJIs) への関心
    • メリット・デメリット
  • 無針技術と競合する技術
    • 新技術(針付き)
    • 吸入技術
    • 経皮貼布技術
  • 無針デリバリー技術が有益となる臨床現場
    • 疼痛管理
    • ワクチンデリバリー
    • 糖尿病患者のためのインスリンデリバリー
    • 小児科における注射
    • その他
  • 無針デリバリー技術市場の規制
    • 米国の規制制度
    • 欧州の規制制度

第3章 世界の無針注射装置市場

  • 無針デリバリー技術市場:概要
  • 無針デリバリー技術市場:セグメント
  • 無針デリバリー市場:予測
  • 無針デリバリー技術:市場動向
  • 無針デリバリー技術:成長促進要因と抑制要因

第4章 ジェット式注射技術市場

  • ジェット式注射器市場
  • ジェット式注射器市場の予測
  • ジェット式注射器市場の主要製品
  • ジェット式注射器開発パイプライン

第5章 競合する無針技術市場

  • 競合する無針技術:概要
  • 競合する無針技術市場予測
  • 競合する無針技術市場予測:主要セグメント別
  • 新しい針技術市場
  • 吸入器技術市場
  • パッチ技術市場
  • その他開発中の競合技術

第6章 主要国の無針デリバリー市場

  • 無針デリバリー市場の主要国内訳
  • 主要国の無針デリバリー市場:予測
  • 米国市場
  • 欧州市場
  • 日本市場
  • 中国市場
  • インド市場

第7章 主要企業

  • Antares Pharma
  • Zogenix
  • 3M
  • BD
  • PharmaJet
  • Bioject Medical Technologies

第8章 無針デリバリー市場の定性分析

  • SWOT分析
  • 強み
  • 弱み
  • 機会
  • 脅威

第9章 専門家の見解

第10章 総論

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PHA0046

Needle-Free Delivery Technology - assess products, developments, and revenue prospects

What does the future hold for the needle-free delivery technology market? Visiongain's brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.

Our 208 page report provides 97 tables, charts, and graphs covering 2 distinct submarket and 3 leading segments. Discover the most lucrative areas in the industry and the future market prospects. You will see financial results, interviews, trends, opportunities, and revenue predictions.

Forecasts from 2015-2025 and other analyses show you commercial prospects

Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT), company profiles and commercial developments. Read the full transcript of five exclusive expert opinion interviews with industry specialists informing your understanding and allowing you to assess prospects for investments and sales:

  • Mr Mark Logomasini, Director of Business Development, Bioject Medical Technologies
  • Mr David Hoey, CEO, Vaxxas
  • Mr Chris Cappello, CTO, PharmaJet
  • Dr D F Chowdhury, CEO, Nemaura
  • Mr Robert E. Sievers, CEO and President, Aktiv-Dry LLC, and Professor, Department of Chemistry and Biochemistry, Center for Pharmaceutical Biotechnology, University of Colorado, Boulder

You will find prospects for key submarkets

In addition to analyses of the overall world market, you will see revenue forecasting of 2 major submarkets and 3 leading segments to 2025:

  • Jet injectors
  • Competing technologies
    • Novel needle technology
    • Inhaler technology
    • Transdermal patch technology

Our new study also provides qualitative analyses for each submarket identifying strengths, weaknesses, opportunities and potential threats to sales growth.

How will those needle-free delivery technology markets expand? Which applications will generate most money? This study will allow you to thoroughly understand the industry, finding the most promising places for investments and sales.

What are the prospects in the leading regions and countries?

Events and progress worldwide will influence the market. In our study you will find individual revenue forecasts to 2025 for the leading regional and national markets:

  • US
  • Japan
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • India
  • China
  • RoW

Many opportunities exist within the needle-free delivery technology market. Greater uptake of existing technology and products worldwide will also stimulate the industry and market. With our new investigation you will gain business research and analysis with individual sales predictions and discussions. You will find analysis of competition, as well as commercial drivers and restraints. See what is likely to achieve the most success.

Leading companies and potential for market growth

Overall world revenue for the needle-free delivery technology market will reach $1.2bn in 2015, our work forecasts. We predict strong revenue growth from 2015 to 2025. Our work shows you what organisations hold greatest potential. See profiles of 6 leading companies and others, including these:

  • Antares Pharma
  • Zogenix
  • 3M
  • BD
  • PharmaJet
  • Bioject Medical Technologies

In general, a company profile gives you the following information:

  • Overview of the company, including its history in the needle-free delivery technology market
  • Discussion of a company's activities and outlook including descriptions of leading products
  • Recent financial results
  • Assessment of recent developments - mergers and acquisitions (M&A), new products, and collaborations, inc. alliances, partnerships and joint ventures

What issues will affect the needle-free delivery technology market?

Our new report discusses issues and events affecting the needle-free delivery technology market. You will find discussions, including qualitative analyses:

  • Increasing clinical evidence of product effectiveness
  • An increasing global diabetes population providing bigger markets for needle-free delivery products
  • The emerging biological product and biosimilar market
  • The unmet needs for vaccination programmes
  • Continuous innovation and a strong R&D pipeline
  • Expansion internationally targeting emerging economies

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Needle-Free Delivery Technology Market Forecast 2015-2025: Opportunities for Leading Companies report helps you

In summary, our 208 page report gives you the following knowledge:

  • Revenues forecasts to 2025 for the overall world needle-free delivery technology market, 2 submarkets and 3 leading segments - discover the industry's prospects, finding promising places for investments and revenues
  • Assessment of leading companies, and others, discovering activities and outlooks
  • Market forecasting to 2025 for the leading regional and national markets - US, Japan, Germany, France, UK, Spain, Italy, India, China and RoW.
  • View opinions from our survey, seeing interviews with authorities
  • Investigation of competition and opportunities influencing sales
  • Discussion of what stimulates and restrains the needle-free delivery technology market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunity. See there how you could benefit your research, analyses, and decisions. Also see how you can save time and get recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the needle-free delivery technology market. You find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Needle-Free Delivery Technology Market Overview
  • 1.2. Overview of Findings
  • 1.3. Structure of the Report
  • 1.4. Global Needle-Free Delivery Technology Market Segmentation
  • 1.5. Why You Should Read This Report
  • 1.6. How This Report Delivers
  • 1.7. Key Questions Answered by This Analytical Report
  • 1.8. Who is This Report For?
  • 1.9. Methodology
  • 1.10. Frequently Asked Questions (FAQ)
  • 1.11. Associated Visiongain Reports
  • 1.12. About Visiongain

2. Introduction to Needle-Free Delivery Technology

  • 2.1. What is Needle-Free Delivery Technology?
    • 2.1.1. Needlestick Injury
      • 2.1.1.1. Blood-Borne Pathogens and Needlestick Injury
      • 2.1.1.2. Accidental Needlestick Injury: A Serious Healthcare Problem
  • 2.2. The Needle-Free Delivery Technology Market
  • 2.3. Jet Injectors
    • 2.3.1. Concerns about Multi-use Nozzle Jet injectors (MUNJIs)
    • 2.3.2. Strengths and Weaknesses of Jet Injectors
  • 2.4. Competing Needle-Free Technologies
    • 2.4.1. Novel Needle Technology
      • 2.4.1.1. Pen Needles
      • 2.4.1.2. Microneedles
      • 2.4.1.3. Hollow Microneedles
      • 2.4.1.4. Solid Coated Microneedles
      • 2.4.1.5. Solid Biodegradable Microneedles
      • 2.4.1.6. Solid Uncoated Microneedles
      • 2.4.1.7. Selection of Microneedles
    • 2.4.2. Inhaler Technology
    • 2.4.3. Transdermal Patch Technology
  • 2.5. Clinical Settings Where Needle-Free Delivery Technology Will Be Beneficial
    • 2.5.1. Pain Management
      • 2.5.1.1. Using Needle-Free Injection Devices to Administer Lidocaine
    • 2.5.2. Vaccine Delivery: Improving Immune Response
      • 2.5.2.1. Needle-Free Vaccine Delivery
      • 2.5.2.2. Mass Immunisation
    • 2.5.3. Insulin Delivery for Diabetics
    • 2.5.4. Paediatric Injections
    • 2.5.5. Other Uses for Needle-Free Injection Technology
  • 2.6. Regulation of the Needle-Free Delivery Technology Market
    • 2.6.1. The US Regulation System
      • 2.6.1.1. Combination Products
      • 2.6.1.2. FDA Statement Clamps Down On Delivery of Medications in Non-approved Needle-Free Devices
    • 2.6.2. The European Regulation System
      • 2.6.2.1. Post Marketing Surveillance in the EU

3. Needle-Free Delivery Technology: World Market 2015-2025

  • 3.1. The Needle-Free Delivery Technology Market: Overview
  • 3.2. Needle-Free Delivery Technology Market Segmentation, 2014
  • 3.3. The Needle-Free Delivery Technology Market Forecast, 2015-2025
  • 3.4. How Will Segmental Market Shares Change to 2025?
  • 3.5. Needle-Free Delivery Technology: Market Trends, 2015-2025
  • 3.6. Needle-Free Delivery Technology: Drivers and Restraints 2015-2025

4. Jet Injectors Technology Market, 2015-2025

  • 4.1. The Jet Injectors Market Overview
  • 4.2. Jet Injectors: Market Forecast 2015-2025
  • 4.3. Jet Injector Devices on the Market
    • 4.3.1. Biojector 2000 (Bioject Medical Technologies)
    • 4.3.2. ZetaJet (Bioject Medical Technologies)
    • 4.3.3. Vision (Antares Pharma)
    • 4.3.4. Vibex (Antares Pharma)
    • 4.3.5. Sumavel DosePro (Endo International)
    • 4.3.6. Stratis (PharmaJet)
    • 4.3.7. LectraJet (D'Antonio Consultants International)
    • 4.3.8. AdvantaJet and GentleJet (Activa Brand Products)
    • 4.3.9. Vitajet (Bioject Medical Technologies)
    • 4.3.10. Med-Jet (Medical International Technologies)
    • 4.3.11. J-Tip (National Medical Products)
    • 4.3.12. Injex30 (Injex Pharma)
    • 4.3.13. SQ-Pen, SQ-X and MHP-1 (Bespak)
    • 4.3.14. E-Jet 100 (Eurojet Medical)
    • 4.3.15. Penjet (Penjet Corporation)
  • 4.4. Jet Injectors Development Pipeline
    • 4.4.1. Glide SDI (Glide Pharmaceutical Technologies)
    • 4.4.2. Zeneo (Crossject)
    • 4.4.3. Relday (Zogenix)
    • 4.4.4. Magnetic Injection (Massachusetts Institute of Technology)
    • 4.4.5. Intradermal (ID) Pen (Bioject Medical Technologies)
    • 4.4.6. Iject and Iject R (Bioject Medical Technologies)
    • 4.4.7. Jupiter Jet (Bioject Medical Technologies)

5. Competing Needle-Free Technology Market, 2015-2025

  • 5.1. The Competing Needle-Free Technology Overview
  • 5.2. The Competing Technology: Market Forecast 2015-2025
  • 5.3. How Will Segmental Market Shares Change to 2025?
  • 5.4. Novel Needle Technology Overview
  • 5.5. Novel Needle Technology: Market Forecast, 2015-2025
    • 5.5.1. Leading Novel Needle Technologies
      • 5.5.1.1. Soluvia Microinjection System (BD)
      • 5.5.1.2. Ultra-Fine Nano 4mm Pen Needle (BD)
      • 5.5.1.3. AutoShield Duo Pen Needle (BD)
      • 5.5.1.4. Microstructured Transdermal Systems (3M)
      • 5.5.1.5. ZP Patch Technology (Zosano)
    • 5.5.2. Novel Needle Technology Development Pipeline
      • 5.5.2.1. Microneedle Patch (Georgia Institute of Technology)
      • 5.5.2.2. Micronjet (NanoPass)
      • 5.5.2.3. DebioJect (Debiotech)
      • 5.5.2.4. AdminPen (nanoBioSciences)
      • 5.5.2.5. PKA SoftTouch (PKA SoftTouch Corp)
      • 5.5.2.6. DrugMat and VaxMat (TheraJect)
      • 5.5.2.7. MicroCor (Corium International)
      • 5.5.2.8. Nanopatch (Vaxxas)
      • 5.5.2.9. Nanotopography Enhanced Microneedle Delivery (University of California-San Francisco, Georgia Institute of Technology and Kimberly-Clark)
      • 5.5.2.10. Memspatch and Micro-Patch (Nemaura)
      • 5.5.2.11. Microneedle Patch for Lidocaine Delivering (National University of Singapore)
  • 5.6. Inhaler Technology Overview
  • 5.7. Inhaler Technology: Market Forecast, 2015-2025
    • 5.7.1. Inhaler Products in the Asthma Market
      • 5.7.1.1. Preventer Inhalers
      • 5.7.1.2. Reliever Inhalers
    • 5.7.2. Inhaler Products in the Insulin Market
      • 5.7.2.1. Afrezza (MannKind)
    • 5.7.3. Inhaler Products in the Vaccine Market
      • 5.7.3.1. FluMist Quadrivalent (MedImmune)
    • 5.7.4. Vaccine Inhaler Pipeline
  • 5.8. Transdermal Patch Technology Overview
  • 5.9. Transdermal Patch Technology: Market Forecast, 2015-2025
    • 5.9.1. Selected Transdermal Patch Products
      • 5.9.1.1. Duragesic (Fentanyl, Janssen Pharmaceuticals)
      • 5.9.1.2. Nicoderm CQ (Nicotine, GlaxoSmithKline)
      • 5.9.1.3. Exelon Patch (Rivastigmine, Novartis)
      • 5.9.1.4. Zecuity (Sumatriptan, Teva)
    • 5.9.2. Transdermal Patch Technology Development Pipeline
      • 5.9.2.1. Electronic Transdermal Patch (Rhenovia Pharma)
      • 5.9.2.2. Electroporation-Mediated DNA Drug Delivery (TriGrid, Ichor Medical Systems)
      • 5.9.2.3. Ultrasonic Waveforms (U-Strip, Transdermal Specialties)
      • 5.9.2.4. Prelude SkinPrep System (Echo Therapeutics)
  • 5.10. Other Competing Needle-free delivery Technology in development
    • 5.10.1. Microbubbles Injection (Shibaura Institute of Technology)
    • 5.10.2. Laser Injection (Seoul National University)
    • 5.10.3. Vaccine Delivery Using Micro-Shock Waves (Indian Institute of Science, Bangalore)
    • 5.10.4. Nanotechnology Syringes (Gwangju Institute of Science and Technology, South Korea)

6. Leading National Markets 2015-2025

  • 6.1. National Breakdown of the World Needle-Free Technology Market
  • 6.2. World Needle-Free Delivery Technology Market: Regional Forecast 2015-2025
    • 6.2.1. How Will Regional Market Shares Change to 2025?
  • 6.3. The US Needle-Free Delivery Technology Market 2015-2025
    • 6.3.1. US Needle-Free Delivery Technology Market Forecast 2015-2025
    • 6.3.2. FDA Guideline for Combination Products
    • 6.3.3. Needle-Free Delivery and the US Flu Vaccination Market
    • 6.3.4. Measles Outbreak in the US
  • 6.4. The EU5 Needle-Free Delivery Technology Market 2015-2025
    • 6.4.1. EU5 Needle-Free Delivery Technology Market Forecast 2015-2025
    • 6.4.2. The German Needle-Free Delivery Technology Market Forecast, 2015-2025
    • 6.4.3. The French Needle-Free Delivery Technology Market Forecast, 2015-2025
    • 6.4.4. The UK Needle-Free Delivery Technology Market Forecast, 2015-2025
    • 6.4.5. The Italian Needle-Free Delivery Technology Market Forecast, 2015-2025
    • 6.4.6. The Spanish Needle-Free Delivery Technology Market Forecast, 2015-2025
  • 6.5. The Japanese Needle-Free Delivery Technology Market 2015-2025
    • 6.5.1. Japanese Needle-Free Delivery Technology Market Forecast 2015-2025
  • 6.6. The Chinese Needle-Free Delivery Technology Market 2015-2025
    • 6.6.1. Chinese Needle-Free Delivery Technology Market Forecast 2015-2025
  • 6.7. The Indian Needle-Free Delivery Technology Market 2015-2025
    • 6.7.1. Indian Needle-Free Delivery Technology Market Forecast 2015-2025
    • 6.7.2. Needles and Syringes Being reused in Indian Hospitals

7. Leading Companies in the Needle-Free Delivery Technology Market

  • 7.1. Leading Needle-Free Delivery Technology Manufacturers in 2014
  • 7.2. Antares Pharma
    • 7.2.1. Antares Pharma: Needle-Free Delivery Technology Product Portfolio
    • 7.2.2. Antares Pharma: Financial Overview
    • 7.2.3. Antares Pharma: Products in Development
    • 7.2.4. Settlement of Patent Infringement Case between Antares Pharma and Medac Pharma
  • 7.3. Zogenix
    • 7.3.1. Zogenix: Product Portfolio
    • 7.3.2. Zogenix: Current Pipeline
    • 7.3.3. Zogenix: Financial Overview
  • 7.4. 3M
    • 7.4.1. 3M: Needle-Free Delivery Technology Product Portfolio
      • 7.4.1.1. 3M: Metered Dose Inhaler
      • 7.4.1.2. 3M: Transdermal patch
      • 7.4.1.3. 3M: Microneedle
    • 7.4.2. 3M: Financial Overview
  • 7.5. BD
    • 7.5.1. BD: Needle-Free Delivery Technology Product Portfolio
    • 7.5.2. BD: Financial Overview
    • 7.5.3. Recall of BD Needles in HongKong
  • 7.6. PharmaJet
    • 7.6.1. PharmaJet: Needle-Free Delivery Technology Product Portfolio
    • 7.6.2. First FDA Approved Jet Injector for Flu Shot in the US
    • 7.6.3. PharmaJet: Collaborations and Needle-Free Delivery Technology Pipeline
    • 7.6.4. Preference for PharmaJet over Needle and Syringe
  • 7.7. Bioject Medical Technologies
    • 7.7.1. Bioject Medical Technologies: Needle-Free Delivery Technology Product Portfolio and Pipeline
    • 7.7.2. Bioject Medical Technologies: Financial Overview
    • 7.7.3. Focusing on Developing Countries

8. Qualitative Analysis of the Needle-Free Delivery Technology Market 2015-2025

  • 8.1. SWOT Analysis of the Needle-Free Delivery Technology Market
  • 8.2. Strengths
    • 8.2.1. Strong Growth in the Biologic Drug Market
    • 8.2.2. Increasing Development in Transdermal Delivery
    • 8.2.3. No Specialist Training Required and No Needlestick Injuries
    • 8.2.4. Eliminating the Cold Chain Problem
  • 8.3. Weaknesses
    • 8.3.1. Healthcare Practitioners are not Familiar with Novel Delivery Systems
    • 8.3.2. Greater Regulatory Scrutiny
    • 8.3.3. Inefficient Manufacturing Processes
  • 8.4. Opportunities
    • 8.4.1. Emerging Economies Offer Significant Growth Opportunities
    • 8.4.2. Mass Immunisation Programmes around the World
    • 8.4.3. Increasing Global Diabetes Population
    • 8.4.4. Shift towards Home Administration Setting
    • 8.4.5. Extending Life Cycle of Drugs
  • 8.5. Threats
    • 8.5.1. Traditional Needles and Syringes are Very Cheap to Mass Produce
    • 8.5.2. Needle and Syringes with Anti Needlestick Injury Technology
    • 8.5.3. Limited Clinical Data
    • 8.5.4. Medical Device Excise Tax

9. Research Interviews

  • 9.1. Interview with Mark Logomasini, Director of Business Development, Bioject Medical Technologies
    • 9.1.1. The Spring-Powered, Gas-Powered and Battery Powered Jet Injector Markets
    • 9.1.2. Other Competing Needle-Free Delivery Platforms
    • 9.1.3. Regulations Determine Jet Injector Market
    • 9.1.4. Small Needle Free Delivery Companies Requires Large External Capital
  • 9.2. Interview with David Hoey, CEO, Vaxxas
    • 9.2.1. Vaxxas's Nanopatch Technology
    • 9.2.2. The Advantages of Using Nanopatch Technology in Developed and Developing Markets
    • 9.2.3. The Challenges of Manufacturing Patch Technology
    • 9.2.4. The Future for the Nanopatch Technology
  • 9.3. Interview with Chris Cappello, CTO, PharmaJet
    • 9.3.1. On Current Collaborations
    • 9.3.2. On potential Competitors and the restraint in the market
    • 9.3.3. The Application of Microneedles and transdermal patches is still limited
    • 9.3.4. On Future Growth of the Jet Injector Market
  • 9.4. Interview with John Turanin, Vice President and General Manager, Zogenix Technologies
    • 9.4.1. The Use of Gas Power in Jet Injectors
    • 9.4.2. The Incentives for Drug Companies in Adopting Needle-Free Delivery
    • 9.4.3. Regulating the Needle-Free Delivery Technology Market
    • 9.4.4. Regional Market Forecasts for Jet Injectors
    • 9.4.5. Jet Injectors: Competitive Space and Restraints on the Market
  • 9.5. Interview with Dr D F Chowdhury, CEO, Nemaura
    • 9.5.1. Current Development of Nemaura
    • 9.5.2. Patented Skin Delivery Platforms
    • 9.5.3. Greatest Restraint: Regulatory Barriers
    • 9.5.4. Advantages over Other Technologies
    • 9.5.5. On Future Trends for the Patch and Microneedle Market
  • 9.6. Interview with Robert E. Sievers, CEO and President, Aktiv-Dry LLC, and Professor, Department of Chemistry and Biochemistry, Center for Pharmaceutical Biotechnology, University of Colorado, Boulder
    • 9.6.1. Aktiv-Dry's PuffHaler
    • 9.6.2. The Benefits of Inhaler Technology
    • 9.6.3. The Competitive Landscape for Measles Inhaler Vaccines
    • 9.6.4. ACTIV DRY'S Collaborations
    • 9.6.5. The Challenges to Introduction Novel Inhaler Technology

10. Conclusions

  • 10.1. The World Needle-Free Technology Market in 2014 and 2015
    • 10.1.1. Current Leading Needle-Free Technology Segments
    • 10.1.2. Notable Needle-Free Technology Companies
    • 10.1.3. Leading Regional Markets
  • 10.2. World Needle-Free Technology Market Forecast 2015-2025
  • 10.3. The Future of the Needle-Free Technology Market?
    • 10.3.1. Biosimilars are a Major Driver of the Needle Free Delivery Market
    • 10.3.2. Strong Pipeline Will Drive the Competing Needle-Free Injection Technology Market

List of Tables

  • Table 1.1: Leading National Needle-Free Delivery Technology Market Forecast 2015-2025 ($m, AGR%, CAGR%)
  • Table 2.1: Classification of Jet Injectors by Method of Propulsion
  • Table 2.2: Strengths and Weaknesses of the Jet Injector Market
  • Table 2.3: Pen Needle Technology by Needle Length
  • Table 2.4: Rationale For Needle-Free Vaccine Delivery
  • Table 2.5: Examples of Needle-Free Vaccine Delivery Systems, 2015
  • Table 2.6: Examples of Needle-Free Insulin Delivery Systems for Diabetics, 2015
  • Table 2.7: FDA Guidance on Regulation of Needle-Free Injectors, 2015
  • Table 3.1: The Needle-Free Delivery Technology Market: Revenue ($m), Market Share (%) by Segment, 2014
  • Table 3.2: The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025
  • Table 4.1: The Jet Injectors Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025
  • Table 5.1: The Competing Needle-Free Technology Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025
  • Table 5.2: Novel Needle Technology Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025
  • Table 5.3: Inhaler Technology Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025
  • Table 5.4: Leading Products in the Asthma Preventer Inhaler Market, 2015
  • Table 5.5: Leading Products in the Asthma Reliever Inhaler Market, 2015
  • Table 5.6: Insulin Inhalers Withdrawal from the Market or Pipeline, 2015
  • Table 5.7: Vaccine Inhalers Currently Under Development, 2015
  • Table 5.8: Transdermal Patch Technology Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025
  • Table 5.9: Transdermal Patch Products, 2015
  • Table 6.1: World Needle-Free Delivery Technology Market: Revenues ($m) by Region, 2014 and 2015
  • Table 6.2: World Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%) by Region, 2014-2025
  • Table 6.3: US Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
  • Table 6.4: EU5 Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
  • Table 6.5: German Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
  • Table 6.6: French Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
  • Table 6.7: UK Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
  • Table 6.8: Italian Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
  • Table 6.9: Spanish Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
  • Table 6.10: Japanese Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
  • Table 6.11: Chinese Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
  • Table 6.12: Indian Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
  • Table 7.1: Antares Pharma: Overview, 2015
  • Table 7.2: Antares Pharma: Product Portfolio 2015
  • Table 7.3: Antares' Revenue ($m) from Major Customers, 2010-2014
  • Table 7.4: Antares Pharma: Revenue ($m), AGR (%), CAGR (%), 2010-2014
  • Table 7.5: Antares Pharma: Products in Development 2015
  • Table 7.6: Zogenix: Overview, 2015
  • Table 7.7: Zogenix: Revenue ($m), AGR (%), CAGR (%), 2010-2014
  • Table 7.8: Zogenix: Revenue ($m) by Type, 2010-2014
  • Table 7.9: 3M: Overview, 2015
  • Table 7.10: 3M: Diabetes Care Revenue ($m), AGR (%), CAGR (%), 2009-2014
  • Table 7.11: BD: Overview, 2015
  • Table 7.12: BD: Needle-Free Delivery Technology Product Portfolio 2015
  • Table 7.13: BD: Revenue ($bn) by Geographic Region, 2012-2014
  • Table 7.14: BD: Diabetes Care Revenue ($m), AGR (%), CAGR (%), 2009-2014
  • Table 7.15: PharmaJet: Overview, 2015
  • Table 7.16: Bioject Medical Technologies: Overview, 2015
  • Table 7.17: Bioject Medical Technologies: Revenue ($m) by Product Line, 2010
  • Table 7.18: Bioject Medical Technologies: Revenue ($m), AGR (%), CAGR (%), 2010-2014
  • Table 8.1: SWOT Analysis of the Needle-Free Delivery Technology Market, 2015-2025
  • Table 8.2: Average Price For Needle-Free Drug/Vaccine Delivery Technology, 2014

List of Figures

  • Figure 1.1: Indian Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
  • Figure 1.2: Global Needle-Free Delivery Technology Market Segmentation Overview, 2015
  • Figure 2.1: Percentage (%) of Needlestick Injuries During the Timeline of Use to Disposal of a Device
  • Figure 3.1: The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%), 2014-2025
  • Figure 3.2: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2014
  • Figure 3.3: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2019
  • Figure 3.4: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2025
  • Figure 3.5: Needle-Free Delivery Technology: Drivers and Restraints 2015-2025
  • Figure 4.1: The Jet Injectors Market: Revenue ($m), AGR (%), 2014-2025
  • Figure 5.1: The Competing Needle-Free Technology Market: Revenue ($m), AGR (%), 2014-2025
  • Figure 5.2: Market Shares (%) of Competing Needle-Free Technology Market Segments, 2014
  • Figure 5.3: Market Shares (%) of Competing Needle-Free Technology Market Segments, 2019
  • Figure 5.4: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2025
  • Figure 5.5: Novel Needle Technology Market: Revenue ($m), AGR (%), 2014-2025
  • Figure 5.6: Inhaler Technology Market: Revenue ($m), AGR (%), 2014-2025
  • Figure 5.7: Transdermal Patch Technology Market: Revenue ($m), AGR (%), 2014-2025
  • Figure 6.1: World Needle-Free Delivery Technology Market: Revenues ($m) by Region, 2014
  • Figure 6.2: World Needle-Free Delivery Technology Market: Revenues ($m) by Region, 2015
  • Figure 6.3: World Needle-Free Delivery Technology Market: Revenues ($m) by Region, 2014-2025
  • Figure 6.4: World Needle-Free Delivery Technology Market: Market Shares (%) by Regional Market, 2014
  • Figure 6.5: World Needle-Free Delivery Technology Market: Market Shares (%) by Regional Market, 2019
  • Figure 6.6: World Needle-Free Delivery Technology Market: Market Shares (%) by Regional Market, 2025
  • Figure 6.7: US Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
  • Figure 6.8: EU5 Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
  • Figure 6.9: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2014
  • Figure 6.10: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2019
  • Figure 6.11: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2025
  • Figure 6.12: German Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
  • Figure 6.13: French Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
  • Figure 6.14: UK Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
  • Figure 6.15: Italian Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
  • Figure 6.16: Spanish Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
  • Figure 6.17: Japanese Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
  • Figure 6.18: Chinese Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
  • Figure 6.19: Indian Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
  • Figure 7.1: Antares' Revenue from Major Customers, 2010-2014
  • Figure 7.2: Antares Pharma: Revenue ($m), AGR (%), 2010-2014
  • Figure 7.3: Zogenix: Revenue ($m), AGR (%), 2010-2014
  • Figure 7.4: Zogenix: Revenue ($m) by Type, 2010-2014
  • Figure 7.5: 3M: Diabetes Care Revenue ($m), AGR (%), 2009-2014
  • Figure 7.6: BD: Revenue ($bn) by Geographic Region, 2012-2014
  • Figure 7.7: BD: Diabetes Care Revenue ($m), AGR (%), 2009-2014
  • Figure 7.8: Bioject Medical Technologies: Revenue Share (%) by Product Line, 2010
  • Figure 7.9: Bioject Medical Technologies: Revenue ($m), AGR (%), 2010-2014
  • Figure 8.1: The Transport Process For a Vaccine

Companies Listed

  • 3M
  • Actavis
  • Activa Brand Products
  • AcuShot
  • Adamis
  • Aktiv-Dry
  • Alkermes
  • Alza
  • Anesiva
  • Antares Pharma
  • Aradigm
  • Astellas Pharma
  • AstraZeneca
  • BD
  • BeadTek
  • Berlex Labs
  • Bespak
  • bioCSL
  • Bioject Medical Technologies
  • Biomedics
  • Boehringer Ingelheim
  • Bristol-Myers Squibb and Somerset Pharmaceuticals
  • Cambridge Consultants
  • CareFusion Corporation
  • CEA-LETI
  • Corium International
  • CosMed
  • Crossject
  • CureVac
  • D'Antonio Consultants International
  • Debiotech
  • Durect
  • Echo Therapeutics
  • Elcam Medical
  • Eli Lilly & Co
  • Endo International
  • Ethical Holdings/Schering
  • Eurojet Medical
  • Ferndale
  • Georgia Institute of Technology
  • Giant Eagle
  • GlaxoSmithKline
  • Glide Pharmaceutical Technologies
  • Hangzhou Hema Medical Equipment
  • Haselmeir GmbH
  • Health-Mor Personal Care
  • Hirtenberger
  • Ichor
  • iHealthNet
  • Immunomic Therapeutics
  • ImmusanT
  • Injex Pharma
  • Invion
  • Janssen Pharmaceuticals
  • Key Pharmaceuticals
  • Kroger
  • LEO Pharma
  • LTS Lohmann Therapie-Systeme
  • MannKind
  • Mecaplast
  • Meda Pharmaceuticals
  • Medac Pharma
  • Medical International Technologies
  • Medi-Ject
  • MedImmune
  • Merck
  • Merck Serono
  • Micron Biomedical
  • Mylan
  • nanoBioSciences
  • NanoPass
  • Napp Pharmaceuticals
  • National Medical Products
  • Nektar Therapeutics
  • Nemaura
  • Nicobrand Limited
  • Novartis
  • Novo Nordisk
  • Novogyne Pharmaceuticals
  • NuPathe
  • Nycomed
  • Ortho-McNeil
  • Owen MumFord Inc
  • Par Pharmaceutical
  • Parke-Davis
  • Penjet Corporation
  • Pernix
  • Pfizer
  • PharmaJet
  • PKA SoftTouch Corp
  • Procter & Gamble
  • ProStrakan
  • Purdue Pharma
  • Radius Health
  • Rhenovia Pharma
  • Rite Aid
  • Roche
  • Sandoz
  • Sanofi
  • Searle Pharmaceuticals
  • Shire
  • SHL Group AB
  • Shwarz-Pharma
  • Société Nationale des Poudres et Explosifs
  • STADA Arzneimittel AG
  • Stat Medical Devices
  • Takeda
  • Teva
  • The Medical House
  • TheraJect
  • TheraTech
  • Transdermal Specialties
  • Trimeris
  • Trinity-Chiesi
  • UCB Pharma
  • University of California-San Francisco
  • Vaxxas
  • Vetter Pharma
  • Vyteris
  • Watson
  • West Pharmaceuticals
  • Westmount Pharmacy
  • Ypsomed AG
  • Zogenix
  • Zosano
  • Zydus Cadila

Other Organisations Mentioned in This Report

  • Ankara University
  • Atlanta's Emory University
  • Bill & Melinda Gates Foundation
  • Gwangju Institute of Science and Technology
  • Indian Institute of Science, Bangalore
  • Massachusetts Institute of Technology
  • National University of Singapore
  • Oxford University
  • Seoul National University
  • Shibaura Institute of Technology
  • University of Texas
  • University of Wisconsin's Hospital
Back to Top